Lawyer (during deposition): And the top-selling opioid at Purdue Pharma was OxyContin, correct? Dr. Richard Sackler (during deposition): Yes. Dr. Richard Sackler is a former president of Purdue ...

Activist Ryan Hampton sees a major flaw in the proposed $7.4 billion bankruptcy settlement reached by the OxyContin maker. While it's potentially one of the largest opioid settlements ever, he ...

Purdue Pharma and the Sackler family have recently reached a $7.4 billion settlement in principle to resolve thousands of lawsuits alleging that OxyContin propelled a widespread opioid addiction ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.

Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over ...

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...

The Stamford, Connecticut-based company submitted the plan to the US Bankruptcy Court for the Southern District of New York, Purdue said in a news release on Wednesday, Mar. 19. The reorganization ...

WASHINGTON — Purdue Pharma asked a bankruptcy judge late ... a deal that would have members of the Sackler family who own the company pay up to $7 billion. The filing is a milestone in a ...